- Proposal to establish a hospital dedicated for surgical essential medicines: a pilot project to strengthen the essential medical service in Korea
-
Kim P
- KMID: 2539910
- J Korean Med Assoc.
- 2023 Feb;66(2):143-151.
- doi: 10.5124/jkma.2023.66.2.143
Background: In December 2022, the Ministry of Health and Welfare of the Korean government announced the “action plan for essential medicine (EM),” featuring that the regional emergency centers in tertiary... -
- CITED
-
- Close
- SHARE
-
- Close
- How do we trade off benefits and harms of anticancer drugs for advanced cancer patients?
-
Kim DY
- KMID: 2539903
- J Korean Med Assoc.
- 2023 Feb;66(2):86-90.
- doi: 10.5124/jkma.2023.66.2.86
Background: The overall survival rate of advanced cancer patients has improved thanks to the development of modern medical treatments, particularly new and innovative chemotherapeutic agents such as targeted therapies and... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis and treatment of sodium hypochlorite poisoning with ingestion of household bleaching agents
-
Moon JM, Chun BJ, Cho YS
- KMID: 2539908
- J Korean Med Assoc.
- 2023 Feb;66(2):123-129.
- doi: 10.5124/jkma.2023.66.2.123
Background: Sodium hypochlorite is commonly used as a household bleaching agent (for example, the Clorox brand). Sodium hypochlorite poisoning with ingestion of a bleaching agent is often observed in clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of the adverse effects of cancer immunotherapy with a focus on the respiratory and nervous systems
-
Park SE
- KMID: 2539907
- J Korean Med Assoc.
- 2023 Feb;66(2):116-122.
- doi: 10.5124/jkma.2023.66.2.116
Background: The incidence of adverse toxic reactions to immunotherapy using immune checkpoint inhibitors is 2-10% in the respiratory system and 3.9% to 12% in the neurologic system. The severity of... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of the adverse effects of cancer immunotherapy with a focus on the gastrointestinal and hepatic systems
-
Cheon J
- KMID: 2539906
- J Korean Med Assoc.
- 2023 Feb;66(2):112-115.
- doi: 10.5124/jkma.2023.66.2.112
Background: Immunotherapy has become established as a new cancer treatment that enhances patients’ immune systems’ ability to fight cancer. Immune checkpoint inhibitors (ICI) have demonstrated remarkable benefits in the treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Managing the adverse effects of cytotoxic chemotherapy at the level of primary healthcare
-
Hong JH
- KMID: 2539904
- J Korean Med Assoc.
- 2023 Feb;66(2):92-104.
- doi: 10.5124/jkma.2023.66.2.92
Background: Despite the increased incidence of cancer, more effective cancer drugs are being developed and cancer patient survival expectancy has been prolonged. Here, we discuss the contribution of primary healthcare... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of the adverse effects of targeted therapy for cancer
-
Ryu H
- KMID: 2539905
- J Korean Med Assoc.
- 2023 Feb;66(2):105-111.
- doi: 10.5124/jkma.2023.66.2.105
Background: Advances in genomics and molecular biology over the past 20 years have resulted in numerous approved molecular targeted cancer therapies. The two main approaches for targeted cancer therapy are... -
- CITED
-
- Close
- SHARE
-
- Close
- Cause-of-death statistics in 2020 in the Republic of Korea
-
Vital Statistics Division, Statistics Korea, Noh H, Seo J, Lee S, Yi N, Park S, Choi YJ, Huh S
- KMID: 2539909
- J Korean Med Assoc.
- 2023 Feb;66(2):132-142.
- doi: 10.5124/jkma.2023.66.2.132
Background: This study analyzed the causes of death in the Korean population in 2020. Methods: Cause-of-death data for 2020 from Statistics Korea were examined based on the Korean Standard Classification of... -
- CITED
-
- Close
- SHARE
-
- Close
